Current Funding Opportunities

VICC Funding Available


The mission of the Vanderbilt-Ingram Cancer Center (VICC) is to alleviate cancer death and suffering through pioneering research; innovative, patient-centered care; and evidence-based prevention, education and community activities. VICC aims to further this mission through a new program for Developmental Research Funding; a multi-tier, rolling pilot funding opportunity focused on supporting novel, innovative cancer-relevant projects. This funding aims to support VICC members conducting high-risk, innovative, impactful research to support the generation of preliminary data required for the submission of external, cancer-relevant grant applications (e.g., NIH R, U, or P type; DOD). The purpose of this funding mechanism is to provide VICC members the option to apply for the level of funding needed to support their project.

Three funding tiers are available to qualified VICC members from Vanderbilt University Medical Center, Vanderbilt University, Meharry Medical College and Tennessee State University. Rolling grants will be awarded for one-year projects beginning in January of 2021, with the possibility of renewal for a second year based on measurable progress of impact.

Three Tiers of Support are Available to VICC Members:

TIER 1 – Requests < $3,000
TIER 2 – Requests between $3,000 and $10,000
TIER 3 – Requests > $10,000

To submit your application, please complete the REDCap survey through the link: and visit the VICC website here for more information.

AACR Career Development Award for Pancreatic Cancer Research

Find all current AACR opportunities here and more here!

NIH National Cancer Institute Early Detection Research Network

Early Detection Research Network (EDRN) Funding Opportunity Announcements (FOAs): EDRN BCC, EDRN CVC, EDRN DMCC

NCI Center to Reduce Cancer Health Disparities (CRCHD)

Training and funding opportunities for CPACHE trainees and investigators:

NCI CURE K08 career development award, entitled NCI Mentored Research Scientist Development Award to Promote Diversity (K08), provides clinical scientists from underrepresented populations with up to five years of protected time for mentored research training and career development support.

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

The NCI Mentored Research Scientist Development Award to Promote Diversity (K01) is designed to enhance workforce diversity by promoting cancer research career development and mentored training experience to individuals from underrepresented groups. Learn more:

NCI Pathway to Independence Award for Outstanding Early State Postdoctoral Researchers

RFA-CA-21-060 (K99/R00 – Independent Clinical Trial Not Allowed)

RFA-CA-21-061 (K99/R00 – Independent Clinical Trial Required)

RFA-CA-21-062  (K99/R00 – Independent Basic Experimental Studies with Humans Required)

Other External Opportunities

The Mark Foundation for Cancer Research Endeavor Award

The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts.

Letter of Intent EXTENDED – Due March 15, 2022

Additional Details here! 

Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (BMSF DCTCDP) is a 2-year program designed to support the career development of early-stage investigator physicians (as defined by NIH) who are underrepresented in medicine(URM) or who have a demonstrated commitment to increasing diversity in clinical research. The program prepares participants to become independent clinical trial investigators engaged in advancing health equity through their research and mentoring.

Letter of Intent Due March 15, 2022

Additional Details here! 

Damon Runyon

Damon Runyon Cancer Research Fellowship – Applications due March 15